3Gong MN,Wei z,Xu LL,et a1.Polymorphism in the surfactant protein-B gene,gender,and the ris k of direct pulmonary injury and ARDS.Chest,2004,125:203-211.
二级参考文献13
1[3]Otis DR, Johnson M, Pedley TJ, et al. Role of pulmonary surfactant in airway closure : A computational study. J Appl Physiol, 1993, 75(3): 1323- 1333.
2[4]Hohlfeld J, Tiryaki E, Hamn H, et al. Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Med, 1998, 158(3): 706- 712.
3[5]McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, or chestrate innate immunity in the lung. J Clin Invest, 2002, 109(6): 707- 712.
4[6]Kremlev SG, Umstead TM, Phelp DS. Surfactant protein A egulates cytokine production in the monocytic cell line THP-1. Am J Physiol, 1997, 272( 5pt 1): L996 - 1004.
5[7]Augusto LA, Li J, Synguelakis M, et al. Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J Biol Chem, 2002, 277(26): 23484- 23492.
6[8]Harrod KS, Trapnell BC, Otaka K, et al. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am J Physiol, 1999, 277(3pt1): L580- 588.
7[12]Hentschel R, Jorch GJ. Acute side effects of surfactant treatment. Perinat Med, 2002, 30(2): 143- 148.
8[13]Walmrath D, Grimminger F, Pappert D, et al. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: Impact on gas exchange and haemodynamics. Eur Respir J, 2002, 19(5): 805- 810.
8Nkadi PO ,Merritt TA,Pillers DA. An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease. Mol Genet Metab,2009,97:95-101.
